P06276 (CHLE_HUMAN) Homo sapiens (Human)
Cholinesterase UniProtKBInterProSTRINGInteractive Modelling
602 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
91 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of recombinant full length human butyrylcholinesterase | homo-8-mer | 99.43 | 4×NAG; 20×NAG; 28×SO4; 20×GOL; | |||
| AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5 | homo-8-mer | 99.62 | 16×NAG; 8×TCX; 24×NAG; 12×SO4; 4×CL; | |||
| Human butyrylcholinesterase in complex with ((6-((2E,4E)-5-(benzo[d][1,3]dioxol-5-yl)penta-2,4-dien… | homo-8-mer | 99.24 | 8×NAG; 8×GAL; 8×NAG; 16×NAG; 16×NAG; 8×GOL; 8×QRH; 8×LEA; 32×CL; 32×SO4; 16×BR; | |||
| NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6 | homo-8-mer | 99.43 | 16×NAG; 8×NAG; 8×TC5; 24×CL; 16×SO4; 8×NA; 24×NAG; | |||
| X-ray Structure of human butyrylcholinesterase inhibited by racemic VX | homo-8-mer | 99.24 | 16×NAG; 8×GLY; 288×UNX; 8×VX; 8×NA; 16×CL; 8×K; 16×SO4; 32×NAG; | |||
| NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5 | homo-8-mer | 99.43 | 16×NAG; 8×NAG; 8×TN7; 8×NA; 16×SO4; 16×CL; 24×NAG; | |||
| NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4 | homo-8-mer | 99.24 | 16×NAG; 8×NAG; 8×TC3; 8×NA; 16×SO4; 32×CL; 24×NAG; | |||
| AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1 | homo-8-mer | 99.43 | 16×NAG; 8×NAG; 8×NA; 24×CL; 8×TN6; 16×SO4; 24×NAG; | |||
| X-ray Structure of human butyrylcholinesterase inhibited by racemic VR | homo-8-mer | 99.24 | 16×NAG; 184×UNX; 8×VR; 8×GLY; 16×SO4; 24×CA; 8×BR; 16×NA; 32×NAG; 8×CL; | |||
| G117H mutant of human butyrylcholinesterase in complex with echothiophate | homo-8-mer | 99.05 | 16×NAG; 8×NAG; 168×UNX; 8×DEP; 8×SO4; 32×CL; 8×BR; 16×NA; 8×CA; 24×NAG; | |||
| Crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-met… | homo-8-mer | 99.05 | 16×NAG; 8×GLY; 32×NAG; 40×CL; 8×BR; 16×CA; 16×NA; 8×15F; | |||
| X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(R) | homo-8-mer | 99.24 | 16×NAG; 8×GLY; 8×VX; 16×SO4; 16×NA; 8×K; 16×CA; 16×CL; 32×NAG; 8×MG; | |||
| X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(S) | homo-8-mer | 99.24 | 8×NAG; 8×GLY; 8×VX; 16×SO4; 8×CA; 8×NA; 16×CL; 8×K; 16×FUC; 48×NAG; 200×UNX; | |||
| Crystal structure of soman-aged human butyrylcholinesterase in complex with 2-PAM | homo-8-mer | 99.05 | 16×NAG; 16×K; 16×SO4; 24×GOL; 24×CL; 8×FP1; 32×NAG; | |||
| G117H mutant of human butyrylcholinesterase in complex with fluoride anion | homo-8-mer | 99.05 | 16×NAG; 8×NAG; 136×UNX; 8×F; 8×SO4; 40×CL; 8×K; 24×NAG; | |||
| STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT | homo-8-mer | 99.43 | 8×NAG; 40×SO4; 8×NA; 8×CL; 8×GOL; 56×NAG; 16×FUC; | |||
| X-ray Structure of human butyrylcholinesterase inhibited by racemic CVX | homo-8-mer | 99.24 | 16×NAG; 8×GLY; 8×CVX; 24×CL; 24×NA; 16×SO4; 32×NAG; 200×UNX; | |||
| G117H mutant of human butyrylcholinesterase in complex with VX | homo-8-mer | 99.05 | 16×NAG; 8×NAG; 56×UNX; 8×VX; 8×SO4; 40×CL; 16×NH4; 24×NAG; | |||
| CryoEM reconstruction of full-length, fully-glycosylated human butyrylcholinesterase tetramer | homo-4-mer | 100 | 8×NAG; | |||
| Co-crystallization studies of full length recombinant BChE with cocaine offers insights into cocain… | homo-4-mer | 100 | 4×BEZ; | |||
| X-ray structure of human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)pip… | homo-2-mer | 100 | 1×NAG; 4×NAG; 2×40V; 10×NAG; 3×FUL; 1×FUC; 4×CL; 4×EDO; | |||
| Aged Form of Human Butyrylcholinesterase Inhibited by Tabun Analogue TA4 | homo-2-mer | 99.24 | 2×NAG; 2×NAG; 2×NAG; 6×NAG; 2×CL; 2×NA; 2×SO4; 2×EFS; 2×F; | |||
| Crystal structure of a variant of human butyrylcholinesterase expressed in bacteria. | homo-2-mer | 91.08 | 6×EDO; 2×PEG; 10×CL; 12×PGE; | |||
| Crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobe… | homo-2-mer | 99.05 | 4×NAG; 2×GLY; 4×NA; 2×K; 2×MF5; 8×NAG; 8×CA; 8×CL; | |||
| Crystal structure of fully glycosylated human butyrylcholinesterase | homo-2-mer | 100 | 2×NAG; 6×NAG; 1×NAG; 2×BAL; 6×NAG; 2×PG4; 19×EDO; 10×UNX; 7×CL; 2×GLY; 2×PEG; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)… | homo-2-mer | 100 | 3×NAG; 3×NAG; 1×NAG; 8×NAG; 2×5HB; 5×GOL; 4×EDO; 6×UNX; 1×FUL; 1×PEG; | |||
| Human Butyrylcholinesterase complexed with N-Propargyliperidines | homo-2-mer | 100 | 1×NAG; 3×NAG; 1×NAG; 1×NAG; 4×CWQ; 3×GOL; 4×EDO; 4×NAG; 5×SO4; 1×CL; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)… | homo-2-mer | 100 | 1×NAG; 2×NAG; 1×NAG; 2×NAG; 5×GOL; 3×EDO; 2×5HH; 2×CL; 9×NAG; | |||
| Structure of recombinant human butyrylcholinesterase in complex with a coumarin-based fluorescent p… | homo-2-mer | 100 | 3×NAG; 1×NAG; 1×NAG; 4×NAG; 6×NAG; 9×EDO; 5×CL; 1×PEG; 1×KJT; 1×PGE; | |||
| Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibito… | homo-2-mer | 100 | 3×NAG; 10×NAG; 2×6QS; 3×EDO; 2×GOL; | |||
| Human butyrylcholinesterase in complex with thioflavine T | homo-2-mer | 100 | 2×NAG; 3×NAG; 1×NAG; 7×NAG; 4×TFX; 2×CL; | |||
| Crystal structure of human butyrylcholinesterase in complex with 2-{1-[4-(12-Amino-3-chloro-6,7,10,… | homo-2-mer | 100 | 2×8U2; | |||
| Human butyrylcholinesterase in complex with propidium | homo-2-mer | 100 | 4×NAG; 8×NAG; 2×PRM; 4×CL; 1×GLY; | |||
| Diethylphosphorylated Butyrylcholinesterase (Nonaged) Obtained By Reaction With Echothiophate | homo-2-mer | 99.24 | 2×NAG; 2×NAG; 2×NAG; 6×NAG; 8×SO4; 4×CL; 2×DEP; 6×GOL; | |||
| X-Ray Structure Of Di-Isopropyl-Phosphoro-Fluoridate (Dfp) Inhibited Butyrylcholinesterase after Ag… | homo-2-mer | 99.24 | 2×NAG; 2×NAG; 6×NAG; 6×SO4; 4×CL; 2×ISP; 8×GOL; | |||
| Ethylphosphorylated Butyrylcholinesterase (Aged) Obtained By Reaction With Echothiophate | homo-2-mer | 99.24 | 2×NAG; 2×NAG; 8×NAG; 6×SO4; 6×CL; 2×EFS; 8×GOL; | |||
| Human Butyrylcholinesterase complexed with N-Propargyliperidines | monomer | 100 | 5×NAG; 1×NAG; 1×NAG; 1×FUL; 2×GOL; 1×6YC; 1×PEG; | |||
| Human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)… | monomer | 100 | 1×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×3F9; 1×GOL; 2×EDO; | |||
| Human Butyrylcholinesterase in complex with (S)-1-(4-((2-(1H-indol-3-yl)ethyl)carbamoyl)benzyl)-N-(… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×MES; 5×GOL; 1×C0I; 1×SIA; 4×SO4; 7×CL; | |||
| Crystal structure of huBChE with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-(dime… | monomer | 99.43 | 2×NAG; 1×NAG; 3×NAG; 2×GOL; 7×SO4; 3×CL; 2×MES; 2×92H; 1×1PG; 1×PEG; | |||
| Nonaged Form of Human Butyrylcholinesterase Inhibited by Tabun | monomer | 99.24 | 2×NAG; 1×NAG; 3×NAG; 1×NA; 2×CL; 1×PO4; | |||
| G117H mutant of human butyrylcholinesterase in complex with sulfate | monomer | 99.05 | 2×NAG; 1×NAG; 23×UNX; 7×CL; 1×NA; 1×GOL; 2×SO4; 3×NAG; | |||
| Structure of human butyrylcholinesterase with 3-(((2-cycloheptylethyl)(methyl)amino)methyl)-N-methy… | monomer | 99.24 | 3×NAG; 2×NAG; 2×GOL; 1×NAG; 1×MES; 1×WXN; 1×CO3; 6×SO4; | |||
| Human butyrylcholinesterase in complex with (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1… | monomer | 99.24 | 3×NAG; 1×NAG; 3×GOL; 2×NAG; 1×AI6; 1×SIA; 1×MES; 4×CL; 4×SO4; | |||
| Crystal structure of human Butyrylcholinesterase in complex with N-((2S,3R)-4-((2,2-dimethylpropyl)… | monomer | 99.24 | 1×NAG; 3×NAG; 2×NAG; 3×GOL; 1×SIA; 1×RNZ; 1×MES; 2×SO4; | |||
| NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1 | monomer | 99.24 | 2×NAG; 1×NAG; 1×TUN; 1×NA; 5×CL; 3×SO4; 3×NAG; | |||
| Human butyrylcholinesterase in complex with decamethonium | monomer | 99.23 | 2×NAG; 1×DME; 4×NAG; 1×SO4; 3×CL; | |||
| Aged Form of Human Butyrylcholinesterase Inhibited by Tabun | monomer | 99.24 | 2×NAG; 1×NAG; 3×NAG; 2×CL; 1×NA; 1×SO4; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 4×GOL; 1×8UW; 1×GOA; 3×SO4; 1×NA; 8×CL; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino… | monomer | 99.24 | 1×NAG; 3×NAG; 1×8IV; 2×NAG; 2×GOL; 1×GOA; 3×SO4; 13×CL; 2×NA; | |||
| human butyrylcholinesterase in complex with a tacrine-methylanacardate hybrid inhibitor | monomer | 99.24 | 1×NAG; 1×GAL; 2×NAG; 1×TKN; 3×NAG; 1×MES; 1×GOL; 3×CL; 3×SO4; | |||
| Human Butyrylcholinesterase in complex with (S)-1-(4-((naphthalen-1-yl)carbamoyl)benzyl)-N-(3-((1,2… | monomer | 99.24 | 2×NAG; 4×NAG; 1×MES; 1×C4I; 1×GOL; 3×SO4; 7×CL; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)… | monomer | 100 | 3×NAG; 2×NAG; 1×NAG; 1×5HF; 4×GOL; 6×EDO; 2×CL; 1×PG4; 1×NAG; | |||
| Recombinant human butyrylcholinesterase in complex with (2S)-N-[2-(1-benzylazepan-4-yl)ethyl]-2-(bu… | monomer | 99.24 | 2×NAG; 1×NAG; 1×NAG; 2×NAG; 1×O0Z; 2×SO4; 1×CL; | |||
| Human butyrylcholinesterase in complex with 2,2'-(((1E,1'E)-(2-phenylpyrimidine-4,6-diyl)bis(methan… | monomer | 99.24 | 2×NAG; 1×N0C; 4×NAG; 1×GOL; 4×SO4; 3×CL; | |||
| Human butyrylcholinesterase in complex with zinc and N,N,N-trimethyl-2-oxo-2-(2-(pyridin-2-ylmethyl… | monomer | 99.24 | 2×NAG; 4×NAG; 1×NH4; 4×GOL; 7×CL; 2×SO4; 2×ZN; 2×LWL; | |||
| Butyrylcolinesterase expressed in CHO cells co-crystallised with a rivastigmine analogue | monomer | 100 | 4×NAG; 1×BY2; 4×GOL; 1×SO4; | |||
| Structure of human butyrylcholinesterase in complex with N-{[2-(benzyloxy)-3-methoxyphenyl]methyl}-… | monomer | 99.24 | 2×NAG; 2×NAG; 2×NAG; 1×MES; 1×XB8; 1×SIA; 1×GOL; 4×SO4; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino… | monomer | 99.24 | 3×NAG; 3×NAG; 3×GOL; 1×9CI; 1×GOA; 6×SO4; 1×NA; 1×CL; | |||
| Structure of human butyrylcholinesterase inhibited by CBDP (2-min soak): Cresyl-phosphoserine adduct | monomer | 99.43 | 1×NAG; 2×NAG; 7×UNX; 3×NAG; 5×SO4; 1×CL; 1×4OJ; | |||
| Human butyrylcholinesterase carbamylated. | monomer | 100 | 1×NAG; 6×NAG; 1×GOL; 1×CL; | |||
| Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino… | monomer | 99.24 | 1×NAG; 2×NAG; 3×SO4; 3×NAG; 1×8IS; 1×GOL; 6×CL; | |||
| Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(2-cycloheptylethyl)-3-(1H-indol-3… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 2×DMS; 1×HUN; 4×GOL; 1×MES; 4×SO4; | |||
| Crystal structure of human butyrylcholinesterase in complex with (2-((1-(benzenesulfonyl)-1H-indol-… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 2×DMS; 1×S6Q; 1×SIA; 3×SO4; 1×MES; 8×GOL; | |||
| Crystal structure of human butyryl cholinesterase | monomer | 99.43 | 2×NAG; 3×NAG; 2×SO4; 2×CL; 1×BUA; 1×MES; 3×GOL; | |||
| Human butyrylcholinesterase in complex with tacrine | monomer | 99.24 | 2×NAG; 4×NAG; 1×FUC; 1×THA; 1×GOL; 2×SO4; 2×CL; 1×FPK; 7×UNX; | |||
| Structure of carbamoylated human butyrylcholinesterase upon reaction with 3-(((2-cycloheptylethyl)(… | monomer | 99.05 | 3×NAG; 1×NAG; 3×SO4; 7×CL; 1×NA; 1×M8X; 2×NAG; 4×GOL; | |||
| Human Butyrylcholinesterase in complex with N-(2-(1H-Indol-3-yl)ethyl)-2-cycloheptyl-N-methylethan-… | monomer | 99.24 | 2×NAG; 1×NAG; 3×NAG; 1×MES; 4×SO4; 2×GOL; 1×IA4; 1×SIA; | |||
| Structure of human butyrylcholinesterase with (3-(((2-cycloheptylethyl)(methyl)amino)methyl)-1H-ind… | monomer | 99.24 | 2×NAG; 1×NAG; 2×NAG; 1×NAG; 5×GOL; 1×MES; 1×GOA; 1×SIA; 1×WXR; 4×SO4; | |||
| Crystal structure of human butyrylcholinesterase in complex with tert-butyl 3-(((2-((1-(benzenesulf… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×MES; 4×SO4; 3×GOL; 1×S8K; 1×NA; | |||
| Crystal structure of human butyrylcholinesterase in complex with tert-butyl 3-(((2-((1-benzyl-1H-in… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×MES; 3×SO4; 2×GOL; 1×S78; | |||
| Crystal structure of soman-aged human butyryl cholinesterase in complex with the substrate analog b… | monomer | 99.42 | 2×NAG; 3×NAG; 1×SO4; 2×CL; 1×VXA; 1×BCH; 1×GOL; | |||
| Structure of hemiacetylated human butyrylcholinesterase upon reaction with 8-(3-(4-(prop-2-yn-1-yl)… | monomer | 99.24 | 2×NAG; 3×NAG; 1×NAG; 3×GOL; 1×JS0; 1×SIA; 1×MES; 1×PPI; 5×SO4; | |||
| Human butyrylcholinesterase in complex with ethopropazine | monomer | 99.24 | 1×NAG; 2×NAG; 1×BUW; 3×NAG; 7×CL; 1×ZN; 1×SO4; | |||
| Crystal structure of human butyryl cholinesterase in complex with a choline molecule | monomer | 99.43 | 2×NAG; 3×NAG; 1×SO4; 2×CL; 1×MES; 1×CHT; 2×GOL; | |||
| Human butyrylcholinesterase in complex with the S enantiomer of a chlorotacrine-tryptophan multi-ta… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×MES; 1×9A5; 3×GOL; 4×SO4; 1×CL; | |||
| Human butyrylcholinesterase in complex with huprine 19 | monomer | 99.24 | 1×NAG; 1×NAG; 1×H19; 4×NAG; 1×BR; 4×CL; 3×SO4; 4×GOL; 1×UNL; | |||
| Human Butyrylcholinesterase in complex with 3-(2-(butyl(2-cycloheptylethyl)amino)ethyl)-1H-indol-6-… | monomer | 99.24 | 2×NAG; 3×NAG; 1×NAG; 1×MES; 1×MOH; 1×A87; 1×SIA; 4×SO4; | |||
| Crystal structure of soman-aged human butyryl cholinesterase | monomer | 99.42 | 2×NAG; 2×NAG; 1×SO4; 1×CL; 1×VXA; 2×GOL; | |||
| Structure of recombinant human butyrylcholinesterase in complex with a fluorescent NBD-based probe | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×JUB; 1×GOL; 5×SO4; 1×DMS; | |||
| Human Butyrylcholinesterase in complex with (S)-N2-butyl-N1-(2-cycloheptylethyl)-3-(1H-indol-3-yl)-… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×HUK; 5×SO4; | |||
| Human Butyrylcholinesterase in complex with (S)-N-(1-((2-cycloheptylethyl)amino)-3-(1H-indol-3-yl)-… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×DMS; 4×GOL; 1×MES; 1×HUQ; 4×SO4; | |||
| Human butyrylcholinesterase in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | monomer | 99.24 | 2×NAG; 2×NAG; 2×NAG; 2×AI0; 5×SO4; 3×CL; | |||
| Human Butyrylcholinesterase in complex with ((S)-2-(butylamino)-N-(2-(4-(dimethylamino)cyclohexyl)e… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×DMS; 4×GOL; 1×MES; 1×HUZ; 4×SO4; | |||
| Structure of recombinant human butyrylcholinesterase in complex with a fluorescent coumarin-based p… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×JU5; 4×SO4; | |||
| Structure of human butyrylcholinesterase in complex with 1-(2,3-dihydro-1H-inden2-yl)piperidin-3-yl… | monomer | 99.24 | 3×NAG; 1×NAG; 1×DMS; 2×GOL; 1×L3H; 2×NAG; 2×SO4; | |||
| Human butyrylcholinesterase in complex with the R enantiomer of a chlorotacrine-tryptophan multi-ta… | monomer | 99.24 | 1×NAG; 2×NAG; 3×NAG; 1×MES; 1×GZ5; 4×SO4; 1×NA; | |||
| Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1R)-3-{4-[(2-methyl-1H-imidazol-… | monomer | 99.24 | 2×NAG; 1×NAG; 1×GOL; 3×NAG; 2×SO4; 1×MXB; | |||
| Human Butyrylcholinesterase in complex with 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-… | monomer | 99.24 | 2×NAG; 1×NAG; 1×GOL; 3×NAG; 1×MXK; 2×SO4; | |||
| Structure of human Butyrylcholinesterase in complex with 10mM HgCl2 | monomer | 99.24 | 2×NAG; 3×NAG; 3×CL; 4×HG; 2×SO4; 3×GOL; 1×BUA; 1×MES; | |||
| Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(3-cycloheptylpropyl)-3-(1H-indol-… | monomer | 99.24 | 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×HUT; 1×DMS; 4×SO4; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6rua.1.A | homo-2-mer | 0.93 | 1×KJT; | 100.00 | ||
| 6i2t.1.B | monomer | 0.88 | 100.00 | |||
| 6i2t.1.A | monomer | 0.87 | 100.00 | |||